Skip to main content
Study: IV palonosetron can prevent, manage chemo-related symptoms

Intravenous palonosetron was effective in preventing chemotherapy-induced nausea and vomiting or managing delayed symptoms in most of the 40 non-Hodgkin lymphoma patients included in a study. The research published in the journal Supportive Care in Cancer found more than 85% of patients overall achieved a complete response.

Full Story: